Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

Saladax Biomedical, Inc. Enters Agreement with Kaan Medikal for Distribution of My5-FU in Turkey

August 8, 2011 By Bio-Medicine.Org

BETHLEHEM, Pa., Aug. 8, 2011 /PRNewswire/ — Saladax Biomedical,
Inc., a privately held company developing and commercializing novel
diagnostic assays to achieve the promise of personalized medicine
for new and existing therapeutics, announced today that Kaan
Medikal will serve as the exclusive distributor of Saladax’s My5-FU
diagnostic test throughout the Turkish market.

My5-FU measures levels of 5-flourouracil (5-FU), a widely used
chemotherapy drug used in conjunction with other drugs in
first-line therapy for colorectal cancer and other solid tumors.
 The assay technology enables oncologists to determine the
optimal dose of 5-FU for each individual patient, thereby
increasing the effectiveness of the drug and lessening the risk of
severe toxicity and side effects.  My5-FU is the first of
Saladax’s innovative dose management tests commercially
available.

“Kaan Medikal is an ideal partner for Saladax as we continue to
expand the distribution and marketing of My5-FU in the European
Union and other significant markets,” said Adrienne Choma, Esq.,
vice president, marketing and sales of Saladax.  “Interest in
Turkey for My5-FU is strong, and we expect that Kaan Medikal’s
market leadership in diagnostic testing and excellent reputation
for quality will enable significant opportunities for growth, which
will translate into improved care for patients undergoing
chemotherapy treatment for colorectal and other solid tumor
cancers.”

Fatih Ordu, general manager of Kaan Medikal, stated, “We are
delighted to be working with Saladax to market My5-FU in Turkey.
 We’re confident that Saladax’s innovative diagnostic test
will allow physicians in our country to better monitor and provide
more accurate treatment to their patients.”

About Saladax Biomedical, Inc.

Saladax Biomedical develops and commercializes novel diagnostic
assays to achieve the promise of personalized medicine through dose
management and companion di

‘/>”/>

SOURCE

Related Articles Read More >

Dexcom One
How Dexcom’s portfolio goes beyond highly-anticipated next-gen G7
A portrait of Stryker executive Siddarth Satish
How Stryker includes users for product design in the digital age
A Medtronic HVAD pump opened up to show the inner workings
Medtronic investigates HVAD pump welds after patient deaths
Galien Foundation 2022 nominees
18 of the world’s most innovative medical technologies

DeviceTalks Weekly.

May 20, 2022
DeviceTalks Boston Post-Game – Editors’ Top Moments, Insulet’s Eric Benjamin on future of Omnipod 5
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech